Abstract
The present invention provides novel pharmaceutically acceptable salts of Gepotidacin, including but not limited to acid addition salts with organic or inorganic acids, such as sulfate, fumarate, citrate, phosphate, and maleate salts. These salts exhibit improved solubility, stability, and pharmacokinetic properties compared to the free base form of Gepotidacin.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Venukathala, Prashanth and PRASHANTH, VENUKATHALA Mr., "GEPOTIDACIN SALTS", Technical Disclosure Commons, (September 10, 2025)
https://www.tdcommons.org/dpubs_series/8578
COinS